Annual CFI
-$5.43 M
+$2.06 M+27.50%
December 31, 2023
Summary
- As of March 12, 2025, ANIK annual cash flow from investing activities is -$5.43 million, with the most recent change of +$2.06 million (+27.50%) on December 31, 2023.
- During the last 3 years, ANIK annual CFI has risen by +$65.84 million (+92.38%).
- ANIK annual CFI is now -113.67% below its all-time high of $39.69 million, reached on December 31, 2019.
Performance
ANIK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$1.82 M
+$1.59 M+46.64%
September 30, 2024
Summary
- As of March 12, 2025, ANIK quarterly cash flow from investing activities is -$1.82 million, with the most recent change of +$1.59 million (+46.64%) on September 30, 2024.
- Over the past year, ANIK quarterly CFI has stayed the same.
- ANIK quarterly CFI is now -104.43% below its all-time high of $41.02 million, reached on December 31, 2019.
Performance
ANIK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$8.87 M
-$1.07 M-13.80%
September 30, 2024
Summary
- As of March 12, 2025, ANIK TTM cash flow from investing activities is -$8.87 million, with the most recent change of -$1.07 million (-13.80%) on September 30, 2024.
- Over the past year, ANIK TTM CFI has stayed the same.
- ANIK TTM CFI is now -122.34% below its all-time high of $39.69 million, reached on December 31, 2019.
Performance
ANIK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ANIK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.5% | 0.0% | 0.0% |
| 3 y3 years | +92.4% | -40.2% | -159.4% |
| 5 y5 years | +89.2% | -186.5% | -122.3% |
ANIK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.0% | +27.5% | -145.1% | +46.6% | -184.4% | at low |
| 5 y | 5-year | -113.7% | +92.4% | -104.4% | +98.0% | -122.3% | +87.6% |
| alltime | all time | -113.7% | +92.4% | -104.4% | +98.0% | -122.3% | +87.6% |
Anika Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.82 M(-46.6%) | -$8.87 M(+13.8%) |
| Jun 2024 | - | -$3.40 M(+88.2%) | -$7.79 M(+33.3%) |
| Mar 2024 | - | -$1.81 M(-1.7%) | -$5.85 M(+7.7%) |
| Dec 2023 | -$5.43 M(-27.5%) | -$1.84 M(+148.3%) | -$5.43 M(-11.3%) |
| Sep 2023 | - | -$741.00 K(-49.1%) | -$6.12 M(-13.4%) |
| Jun 2023 | - | -$1.46 M(+4.9%) | -$7.07 M(-6.4%) |
| Mar 2023 | - | -$1.39 M(-45.1%) | -$7.55 M(+0.8%) |
| Dec 2022 | -$7.49 M(+140.1%) | -$2.53 M(+49.6%) | -$7.49 M(+20.8%) |
| Sep 2022 | - | -$1.69 M(-12.8%) | -$6.20 M(+6.8%) |
| Jun 2022 | - | -$1.94 M(+46.3%) | -$5.80 M(-6.1%) |
| Mar 2022 | - | -$1.33 M(+6.9%) | -$6.18 M(+98.1%) |
| Dec 2021 | -$3.12 M(-95.6%) | -$1.24 M(-4.2%) | -$3.12 M(-120.9%) |
| Sep 2021 | - | -$1.29 M(-44.1%) | $14.93 M(-35.0%) |
| Jun 2021 | - | -$2.32 M(-233.6%) | $22.95 M(-0.1%) |
| Mar 2021 | - | $1.73 M(-89.7%) | $22.97 M(-132.2%) |
| Dec 2020 | -$71.26 M(-279.5%) | $16.81 M(+149.8%) | -$71.26 M(+51.5%) |
| Sep 2020 | - | $6.73 M(-392.7%) | -$47.05 M(-9.0%) |
| Jun 2020 | - | -$2.30 M(-97.5%) | -$51.68 M(+1.5%) |
| Mar 2020 | - | -$92.50 M(-325.5%) | -$50.90 M(-228.2%) |
| Dec 2019 | $39.69 M(-179.0%) | $41.02 M(+1853.5%) | $39.69 M(-1114.1%) |
| Sep 2019 | - | $2.10 M(-238.5%) | -$3.91 M(-93.6%) |
| Jun 2019 | - | -$1.52 M(-20.9%) | -$61.16 M(+16.8%) |
| Mar 2019 | - | -$1.92 M(-25.7%) | -$52.38 M(+4.2%) |
| Dec 2018 | -$50.26 M(+302.7%) | -$2.58 M(-95.3%) | -$50.26 M(+3.8%) |
| Sep 2018 | - | -$55.14 M(-859.5%) | -$48.40 M(-1521.9%) |
| Jun 2018 | - | $7.26 M(+3407.2%) | $3.40 M(-128.7%) |
| Mar 2018 | - | $207.00 K(-128.6%) | -$11.85 M(-5.1%) |
| Dec 2017 | -$12.48 M(+84.5%) | -$724.00 K(-78.3%) | -$12.48 M(+9.4%) |
| Sep 2017 | - | -$3.34 M(-58.2%) | -$11.41 M(+8.0%) |
| Jun 2017 | - | -$7.99 M(+1780.5%) | -$10.56 M(+91.3%) |
| Mar 2017 | - | -$425.00 K(-223.2%) | -$5.52 M(-18.4%) |
| Dec 2016 | -$6.76 M(-77.6%) | $345.00 K(-113.9%) | -$6.76 M(-66.3%) |
| Sep 2016 | - | -$2.49 M(-15.6%) | -$20.05 M(-8.6%) |
| Jun 2016 | - | -$2.95 M(+77.0%) | -$21.94 M(-15.2%) |
| Mar 2016 | - | -$1.67 M(-87.1%) | -$25.89 M(-14.4%) |
| Dec 2015 | -$30.23 M(+264.0%) | -$12.94 M(+195.1%) | -$30.23 M(+547.1%) |
| Sep 2015 | - | -$4.38 M(-36.4%) | -$4.67 M(-77.2%) |
| Jun 2015 | - | -$6.90 M(+14.8%) | -$20.53 M(+46.3%) |
| Mar 2015 | - | -$6.01 M(-147.6%) | -$14.03 M(+69.0%) |
| Dec 2014 | -$8.30 M(+3181.8%) | $12.62 M(-162.3%) | -$8.30 M(-61.3%) |
| Sep 2014 | - | -$20.24 M(+4950.4%) | -$21.47 M(+1911.4%) |
| Jun 2014 | - | -$400.80 K(+45.0%) | -$1.07 M(+69.6%) |
| Mar 2014 | - | -$276.50 K(-49.6%) | -$629.40 K(+148.7%) |
| Dec 2013 | -$253.00 K(-83.2%) | -$548.10 K(-446.7%) | -$253.10 K(-405.7%) |
| Sep 2013 | - | $158.10 K(+326.1%) | $82.80 K(-137.2%) |
| Jun 2013 | - | $37.10 K(-62.8%) | -$222.30 K(-81.2%) |
| Mar 2013 | - | $99.80 K(-147.0%) | -$1.18 M(-21.5%) |
| Dec 2012 | -$1.50 M(+7.5%) | -$212.20 K(+44.4%) | -$1.50 M(-13.5%) |
| Sep 2012 | - | -$147.00 K(-84.0%) | -$1.74 M(-8.0%) |
| Jun 2012 | - | -$921.40 K(+311.2%) | -$1.89 M(+22.1%) |
| Mar 2012 | - | -$224.10 K(-49.8%) | -$1.55 M(+10.5%) |
| Dec 2011 | -$1.40 M(-47.7%) | -$446.40 K(+49.7%) | -$1.40 M(-27.1%) |
| Sep 2011 | - | -$298.20 K(-48.5%) | -$1.92 M(-20.9%) |
| Jun 2011 | - | -$579.20 K(+656.1%) | -$2.43 M(+23.2%) |
| Mar 2011 | - | -$76.60 K(-92.1%) | -$1.97 M(-26.5%) |
| Dec 2010 | -$2.68 M(-86.7%) | -$967.30 K(+20.1%) | -$2.68 M(-85.5%) |
| Sep 2010 | - | -$805.40 K(+562.9%) | -$18.52 M(-0.2%) |
| Jun 2010 | - | -$121.50 K(-84.5%) | -$18.56 M(-6.0%) |
| Mar 2010 | - | -$785.50 K(-95.3%) | -$19.73 M(-2.4%) |
| Dec 2009 | -$20.22 M(+57.9%) | -$16.81 M(+1889.0%) | -$20.22 M(+317.6%) |
| Sep 2009 | - | -$845.00 K(-34.9%) | -$4.84 M(-33.4%) |
| Jun 2009 | - | -$1.30 M(+2.3%) | -$7.26 M(-48.2%) |
| Mar 2009 | - | -$1.27 M(-11.3%) | -$14.02 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | -$12.80 M(-30.0%) | -$1.43 M(-56.2%) | -$12.80 M(-35.6%) |
| Sep 2008 | - | -$3.27 M(-59.4%) | -$19.90 M(-0.8%) |
| Jun 2008 | - | -$8.05 M(>+9900.0%) | -$20.06 M(+41.7%) |
| Mar 2008 | - | -$55.30 K(-99.4%) | -$14.16 M(-22.6%) |
| Dec 2007 | -$18.28 M(+1300.1%) | -$8.52 M(+148.2%) | -$18.28 M(+84.6%) |
| Sep 2007 | - | -$3.43 M(+60.1%) | -$9.90 M(+50.0%) |
| Jun 2007 | - | -$2.14 M(-48.7%) | -$6.60 M(+28.9%) |
| Mar 2007 | - | -$4.18 M(+2828.4%) | -$5.12 M(+292.2%) |
| Dec 2006 | -$1.31 M(-18.4%) | -$142.80 K(+9.0%) | -$1.31 M(-22.2%) |
| Sep 2006 | - | -$131.00 K(-80.3%) | -$1.68 M(-27.2%) |
| Jun 2006 | - | -$665.80 K(+81.8%) | -$2.31 M(+21.3%) |
| Mar 2006 | - | -$366.30 K(-29.0%) | -$1.90 M(+18.8%) |
| Dec 2005 | -$1.60 M(-564.9%) | -$516.10 K(-32.0%) | -$1.60 M(+40.6%) |
| Sep 2005 | - | -$758.60 K(+191.0%) | -$1.14 M(+99.1%) |
| Jun 2005 | - | -$260.70 K(+299.2%) | -$571.70 K(+958.7%) |
| Mar 2005 | - | -$65.30 K(+21.6%) | -$54.00 K(-115.7%) |
| Dec 2004 | $344.30 K(-76.8%) | -$53.70 K(-72.0%) | $344.30 K(-234.0%) |
| Sep 2004 | - | -$192.00 K(-174.7%) | -$257.00 K(-12.0%) |
| Jun 2004 | - | $257.00 K(-22.8%) | -$292.00 K(-115.3%) |
| Mar 2004 | - | $333.00 K(-150.8%) | $1.91 M(+28.9%) |
| Dec 2003 | $1.49 M(-7.5%) | -$655.00 K(+188.5%) | $1.49 M(-67.4%) |
| Sep 2003 | - | -$227.00 K(-109.2%) | $4.56 M(+2.7%) |
| Jun 2003 | - | $2.46 M(-2665.6%) | $4.44 M(-1043.6%) |
| Mar 2003 | - | -$96.00 K(-104.0%) | -$470.50 K(-129.3%) |
| Dec 2002 | $1.60 M(-68.6%) | $2.42 M(-798.5%) | $1.60 M(-273.8%) |
| Sep 2002 | - | -$346.30 K(-85.8%) | -$923.30 K(-134.9%) |
| Jun 2002 | - | -$2.45 M(-223.6%) | $2.65 M(-65.2%) |
| Mar 2002 | - | $1.98 M(-1911.1%) | $7.61 M(+48.8%) |
| Dec 2001 | $5.11 M(+61.4%) | -$109.30 K(-103.4%) | $5.11 M(-30.7%) |
| Sep 2001 | - | $3.23 M(+28.4%) | $7.38 M(+34.6%) |
| Jun 2001 | - | $2.51 M(-588.7%) | $5.49 M(-2292.4%) |
| Mar 2001 | - | -$513.90 K(-123.8%) | -$250.20 K(-107.9%) |
| Dec 2000 | $3.17 M(-186.8%) | $2.16 M(+62.8%) | $3.17 M(-48.5%) |
| Sep 2000 | - | $1.33 M(-141.2%) | $6.16 M(+879.0%) |
| Jun 2000 | - | -$3.22 M(-211.0%) | $628.80 K(-83.2%) |
| Mar 2000 | - | $2.90 M(-43.6%) | $3.75 M(-202.8%) |
| Dec 1999 | -$3.65 M(-74.6%) | $5.15 M(-222.6%) | -$3.65 M(-62.0%) |
| Sep 1999 | - | -$4.20 M(+4100.0%) | -$9.60 M(-44.8%) |
| Jun 1999 | - | -$100.00 K(-97.8%) | -$17.40 M(-4.9%) |
| Mar 1999 | - | -$4.50 M(+462.5%) | -$18.30 M(+27.1%) |
| Dec 1998 | -$14.40 M(+3500.0%) | -$800.00 K(-93.3%) | -$14.40 M(+2.9%) |
| Sep 1998 | - | -$12.00 M(+1100.0%) | -$14.00 M(+600.0%) |
| Jun 1998 | - | -$1.00 M(+66.7%) | -$2.00 M(+100.0%) |
| Mar 1998 | - | -$600.00 K(+50.0%) | -$1.00 M(+150.0%) |
| Dec 1997 | -$400.00 K(+300.0%) | -$400.00 K(<-9900.0%) | -$400.00 K(<-9900.0%) |
| Sep 1997 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 1997 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
| Mar 1997 | - | $0.00(0.0%) | -$100.00 K(-50.0%) |
| Dec 1996 | -$100.00 K(-75.0%) | - | - |
| Nov 1996 | - | $0.00(-100.0%) | -$200.00 K(-50.0%) |
| Aug 1996 | - | -$100.00 K(<-9900.0%) | -$400.00 K(-20.0%) |
| Aug 1996 | -$400.00 K(+33.3%) | - | - |
| May 1996 | - | $0.00(-100.0%) | -$500.00 K(-16.7%) |
| Feb 1996 | - | -$100.00 K(-50.0%) | -$600.00 K(+20.0%) |
| Nov 1995 | - | -$200.00 K(0.0%) | -$500.00 K(+66.7%) |
| Aug 1995 | -$300.00 K(+50.0%) | -$200.00 K(+100.0%) | -$300.00 K(+50.0%) |
| May 1995 | - | -$100.00 K(<-9900.0%) | -$200.00 K(+100.0%) |
| Feb 1995 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
| Nov 1994 | - | $0.00(-100.0%) | -$100.00 K(-50.0%) |
| Aug 1994 | -$200.00 K(-85.7%) | -$100.00 K(<-9900.0%) | -$200.00 K(+100.0%) |
| May 1994 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
| Feb 1994 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
| Nov 1993 | - | -$100.00 K | -$100.00 K |
| Aug 1993 | -$1.40 M | - | - |
FAQ
- What is Anika Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Anika Therapeutics?
- What is Anika Therapeutics annual CFI year-on-year change?
- What is Anika Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Anika Therapeutics?
- What is Anika Therapeutics quarterly CFI year-on-year change?
- What is Anika Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Anika Therapeutics?
- What is Anika Therapeutics TTM CFI year-on-year change?
What is Anika Therapeutics annual cash flow from investing activities?
The current annual CFI of ANIK is -$5.43 M
What is the all time high annual CFI for Anika Therapeutics?
Anika Therapeutics all-time high annual cash flow from investing activities is $39.69 M
What is Anika Therapeutics annual CFI year-on-year change?
Over the past year, ANIK annual cash flow from investing activities has changed by +$2.06 M (+27.50%)
What is Anika Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ANIK is -$1.82 M
What is the all time high quarterly CFI for Anika Therapeutics?
Anika Therapeutics all-time high quarterly cash flow from investing activities is $41.02 M
What is Anika Therapeutics quarterly CFI year-on-year change?
Over the past year, ANIK quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Anika Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ANIK is -$8.87 M
What is the all time high TTM CFI for Anika Therapeutics?
Anika Therapeutics all-time high TTM cash flow from investing activities is $39.69 M
What is Anika Therapeutics TTM CFI year-on-year change?
Over the past year, ANIK TTM cash flow from investing activities has changed by $0.00 (0.00%)